“…Besides, to ensure uniformity in defining both patient characteristics for endometrial cancer and clinical efficacy measures, a meta-analysis of individual patient data is needed (Simmonds et al, 2005). Second, the clinical outcomes of TAH or TLH and bilateral salpingooophorectomy and/or pelvic and/or para-aortic lymph node dissection differed, but we didn't perform subgroup analyses according to the combined treatment status such as salpingooophorectomy and/or pelvic and/or para-aortic lymph node dissection owing to the limited studies reported in the original papers (Ju et al, 2009;Palomba et al, 2009;Kehoe and Miller, 2011;Saso et al, 2011). Thus, further studies could compare TAH and TLH according to the different status of the combined treatment.…”